Lehrstuhl für Innere Medizin I (Medizin 1)


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure (2020) Schulz-Kuhnt A, Greif V, Hildner K, Knipfer L, Döbrönti M, Zirlik S, Fuchs F, et al. Journal article Retrograde inspection vs standard forward view for the detection of colorectal adenomas during colonoscopy: A back-to-back randomized clinical trial (2020) Rath T, Pfeifer L, Neufert C, Kremer A, Leppkes M, Hoffman A, Neurath M, Zopf S Journal article Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease (2020) Mayr L, Grabherr F, Schwrzler J, Reitmeier I, Sommer F, Gehmacher T, Niederreiter L, et al. Journal article Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients (2020) Breidert M, Eftekhari P, Louis F, Rotoiu C, Rath T, Neurath M, Atreya R Journal article Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy (2020) Ganzleben I, Hirschmann S, Köhler J, Fuchs F, Rieker R, Baer E, Klenske E, et al. Journal article Swept source cross-polarized optical coherence tomography for any input polarized light (2020) Sharma G, Sharma S, Blessing K, Hartl G, Waldner M, Singh K Journal article The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis (2020) Schmitt H, Ulmschneider J, Billmeier U, Scarozza P, Sonnewald S, Reid S, Atreya I, et al. Journal article, Original article CLARINET FORTE Baseline Characteristics: Lanreotide Autogel 120 mg (LAN) Every 14 Days in Patients With Progressive Pancreatic or Midgut Neuroendocrine Tumors During a Standard First-Line LAN Regimen (2020) Ruszniewski P, Cwikla J, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Xuan-Mai Truong Thanh , et al. Conference contribution Investigating Intestinal Barrier Breakdown in Living Organoids (2020) Bardenbacher M, Ruder B, Britzen-Laurent N, Naschberger E, Becker C, Palmisano R, Stürzl M, Tripal P Journal article, Original article